which companies make glp 1 drugs Market Overview: GLP-1 Agonists and the Obesity Market | Blog GLP-1 Medications for Weight Loss

Does Medicare Cover Breast Implant Removal

It works best when paired with strength training and a balanced protein intake

The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice

Tirzepatide (Mounjaro / Zepbound) Mounjaro and Zepbound contain tirzepatide, a newer agent that targets two hormonal pathways simultaneously, GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)

Each reshaped medicine, but also brought unintended consequences: overprescribing, affordability crises, and backlash when the costs or risks became undeniable

Injectable GLP-1s: Nearly 100% bioavailability Consistent, predictable absorption Doses of 1-2.4mg weekly for semaglutide FDA-Approved Oral Tablets: 0.4-1% bioavailability Requires 7-25mg doses to achieve similar effects Must be taken with specific timing and fasting requirements Compounded ODT Formulations: Theoretical bioavailability advantage over swallowed tablets Sublingual/buccal delivery bypasses stomach acid and first-pass metabolism However, research on peptide delivery shows challenges: peptides may be degraded by salivary enzymes, have poor permeability due to large molecular size, and face continuous wash-away from saliva No clinical trials have established actual bioavailability or effectiveness for compounded GLP-1 ODTs These formulations are not FDA-approved and haven't undergone rigorous testing The theoretical advantage of ODT formulations is that by dissolving in the mouth rather than the stomach, they could achieve better absorption than swallowed tablets while maintaining the convenience of a daily, needle-free option